Vimarsana
Biggest News Aggregation in the World

Timefolio Asset News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Timefolio Asset. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Timefolio Asset Today - Breaking & Trending Today

AevisBio Publishes Data with NIH Demonstrating Novel Immunomodulatory Imide Drug Reduces Neuroinflammation and Prevents Cognitive Impairment in Alzheimer's Disease Model - Vimarsana News

AevisBio Publishes Data with NIH Demonstrating Novel Immunomodulatory Imide Drug Reduces Neuroinflammation and Prevents Cognitive Impairment in Alzheimer's Disease Model

AevisBio Publishes Data with NIH Demonstrating Novel Immunomodulatory Imide Drug Reduces Neuroinflammation and Prevents Cognitive Impairment in Alzheimer’s Disease Model - read this article along with other careers information, tips and advice on BioSpace

Follow the Money: Spatial Omics, CAR-NK Cells, AI-Powered Biology - Vimarsana News

Follow the Money: Spatial Omics, CAR-NK Cells, AI-Powered Biology

December 21, 2020 December 21, 2020 | Funding updates around the life sciences including cash for a handheld mass spec device, Series D for oncolytic immunotherapy, a new company launch in allogenic CAR-NK cells, AI-powered cell classification, a 3-D sequencing platform, and more. $170M: Israeli ‘Digital Health First’ VC Firm OTV (formerly Olive Tree Ventures), Israel’s ‘digital health first’ venture capital firm, today announced the closing of a fund with a total value of $170M. OTV also announced their new name and the appointment of a new Head of Asia Pacific to spea...